Mark Applebaum to Combined Modality Therapy
This is a "connection" page, showing publications Mark Applebaum has written about Combined Modality Therapy.
Connection Strength
0.185
-
Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project. Eur J Cancer. 2017 02; 72:177-185.
Score: 0.111
-
Clinical features and outcomes in patients with extraskeletal Ewing sarcoma. Cancer. 2011 Jul 01; 117(13):3027-32.
Score: 0.074